NM_033419.5:c.*559C>T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_033419.5(PGAP3):c.*559C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00298 in 156,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033419.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00295 AC: 449AN: 152224Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00389 AC: 18AN: 4628Hom.: 0 Cov.: 0 AF XY: 0.00488 AC XY: 12AN XY: 2460
GnomAD4 genome AF: 0.00295 AC: 449AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.00285 AC XY: 212AN XY: 74484
ClinVar
Submissions by phenotype
Hyperphosphatasia with intellectual disability syndrome 4 Pathogenic:1Uncertain:3
NM_033419.3:c.*559C>T in the PGAP3 gene has an allele frequency of 0.006 in European (non-Finnish) subpopulation in the gnomAD database. Two sibblings affected with hyperphosphatasia with mental retardation syndrome, were compound heterozygotes for this variant and a missense c.861G>T mutation (PMID: 27120253). Benign computational verdict because benign predictions from DANN, FATHMM-MKL and MutationTaster. We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BP4, PM3. -
Disease causing variant in homozygous or compound heterozygous state. New miRNA binding site is formed and transcript is severly downregulated when the common variant c.*560A>G is also present -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at